日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Retraction Note: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

撤稿声明:利福昔明会改变肠道菌群组成,但不会影响全身炎症——一项针对常见变异型免疫缺陷的随机对照试验

Jørgensen, S F; Macpherson, M E; Bjørnetrø, T; Holm, K; Kummen, M; Rashidi, A; Michelsen, A E; Lekva, T; Halvorsen, B; Trøseid, M; Mollnes, T E; Berge, R K; Yndestad, A; Ueland, T; Karlsen, T H; Aukrust, P; Hov, J R; Fevang, B

Severely ill COVID-19 patients have altered circulating levels of proteins controlling the epitranscriptome

重症 COVID-19 患者体内控制表观转录组的循环蛋白水平发生改变。

Quiles-Jiménez, A; Sousa, M M L; Huse, C; Dyrhol-Riise, A M; Holter, J C; Christensen, E E; Tonby, K; Holten, A R; Aukrust, P; Bjørås, M; Dahl, T B; Halvorsen, B

Increased inflammatory markers reflecting fibrogenesis are independently associated with cardiac involvement in hospitalized COVID-19 patients

反映纤维化过程的炎症标志物升高与住院 COVID-19 患者的心脏受累独立相关

Ueland, T; Dyrhol-Riise, A M; Woll, B M; Holten, A R; Petteresen, F; Lind, A; Dudman, S G; Heggelund, L; Holter, J C; Aukrust, P

Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure

新冠肺炎呼吸衰竭患者循环中MMP-9水平显著且早期升高

Ueland, T; Holter, J C; Holten, A R; Müller, K E; Lind, A; Bekken, G K; Dudman, S; Aukrust, P; Dyrhol-Riise, A M; Heggelund, L

Serum osteoprotegrin (OPG) in subclinical atherosclerosis in systemic lupus erythematosus

系统性红斑狼疮亚临床动脉粥样硬化患者的血清骨保护素(OPG)

Kiani, A N; Aukrust, P; Ueland, T; Hollan, I; Barr, E; Magder, L S; Petri, M

Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS)

晚期获得性免疫缺陷综合征(AIDS)患者体内CCL19水平升高

Damås, J K; Øktedalen, O; Ueland, T; Landrø, L; Barstad, J; Müller, F; Frøland, S S; Flo, T H; Aukrust, P

Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study

慢性阻塞性肺病中的全身炎症标志物:卑尔根慢性阻塞性肺病队列研究的结果

T M L Eagan, T Ueland, P D Wagner, J A Hardie, T E Mollnes, J K Damås, P Aukrust, P S Bakke

Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation

趋化因子与常见变异型免疫缺陷;CCL19、CCL21 和 CCR7 对免疫失调的可能作用

Fevang, B; Yndestad, A; Damås, J K; Halvorsen, B; Holm, A M; Beiske, K; Aukrust, P; Frøland, S S

Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapy.

人类免疫缺陷病毒感染患者血清脂质运载蛋白-2 水平降低:在高效抗逆转录病毒治疗期间升高

Landrø L, Damås J K, Flo T H, Heggelund L, Ueland T, Tjønnfjord G E, Espevik T, Aukrust P, Frøland S S

Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia.

常见变异型免疫缺陷中大颗粒淋巴细胞的多克隆扩增——与中性粒细胞减少症相关

Holm A M, Tjønnfjord G, Yndestad A, Beiske K, Müller F, Aukrust P, Frøland S S